Literature DB >> 21164078

Mitral valve endothelial cells with osteogenic differentiation potential.

Jill Wylie-Sears1, Elena Aikawa, Robert A Levine, Jeong-Hee Yang, Joyce Bischoff.   

Abstract

OBJECTIVE: Cardiac valvular endothelium is unique in its ability to undergo endothelial-to-mesenchymal transformation, a differentiation process that is essential for valve development and has been proposed as mechanism for replenishing the interstitial cells of mature valves. We hypothesized that the valvular endothelium contains endothelial cells that are direct precursors to osteoblastic valvular interstitial cells (VICs). METHODS AND
RESULTS: Clonal cell populations from ovine mitral valve leaflets were isolated by single cell plating. Mitral valvular endothelial and mesenchymal clones were tested for osteogenic, adipogenic, and chondrogenic differentiation, determined by the expression of lineage-specific markers. Mitral valvular endothelial clones showed a propensity for osteogenic, as well as chondrogenic differentiation that was comparable to a mitral valvular VIC clone and to bone marrow-derived mesenchymal stem cells. Osteogenic differentiation was not detected in nonvalvular endothelial cells. Regions of osteocalcin expression, a marker of osteoblastic differentiation, were detected along the endothelium of mitral valves that had been subjected in vivo to mechanical stretch.
CONCLUSIONS: Mitral valve leaflets contain endothelial cells with multilineage mesenchymal differentiation potential, including osteogenic differentiation. This unique feature suggests that postnatal mitral valvular endothelium harbors a reserve of progenitor cells that can contribute to osteogenic and chondrogenic VICs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21164078      PMCID: PMC3210435          DOI: 10.1161/ATVBAHA.110.216184

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  40 in total

1.  Mature vascular endothelium can give rise to smooth muscle cells via endothelial-mesenchymal transdifferentiation: in vitro analysis.

Authors:  Maria G Frid; Vishakha A Kale; Kurt R Stenmark
Journal:  Circ Res       Date:  2002-06-14       Impact factor: 17.367

2.  Multilineage potential of cells from the artery wall.

Authors:  Yin Tintut; Zeni Alfonso; Trishal Saini; Kristen Radcliff; Karol Watson; Kristina Boström; Linda L Demer
Journal:  Circulation       Date:  2003-10-27       Impact factor: 29.690

3.  Human umbilical vein endothelium-derived cells retain potential to differentiate into smooth muscle-like cells.

Authors:  Akira Ishisaki; Hisaki Hayashi; Ai-Jun Li; Toru Imamura
Journal:  J Biol Chem       Date:  2002-11-01       Impact factor: 5.157

4.  A simplified method for growth of human microvascular endothelial cells results in decreased senescence and continued responsiveness to cytokines and growth factors.

Authors:  B M Kräling; J Bischoff
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-04       Impact factor: 2.416

5.  Identification and characterization of calcifying valve cells from human and canine aortic valves.

Authors:  E R Mohler; M K Chawla; A W Chang; N Vyavahare; R J Levy; L Graham; F H Gannon
Journal:  J Heart Valve Dis       Date:  1999-05

6.  Multilineage potential of adult human mesenchymal stem cells.

Authors:  M F Pittenger; A M Mackay; S C Beck; R K Jaiswal; R Douglas; J D Mosca; M A Moorman; D W Simonetti; S Craig; D R Marshak
Journal:  Science       Date:  1999-04-02       Impact factor: 47.728

7.  Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo.

Authors:  S Kaushal; G E Amiel; K J Guleserian; O M Shapira; T Perry; F W Sutherland; E Rabkin; A M Moran; F J Schoen; A Atala; S Soker; J Bischoff; J E Mayer
Journal:  Nat Med       Date:  2001-09       Impact factor: 53.440

8.  Human aortic valve calcification is associated with an osteoblast phenotype.

Authors:  Nalini M Rajamannan; Malayannan Subramaniam; David Rickard; Stuart R Stock; Janis Donovan; Margaret Springett; Thomas Orszulak; David A Fullerton; A J Tajik; Robert O Bonow; Thomas Spelsberg
Journal:  Circulation       Date:  2003-04-28       Impact factor: 29.690

9.  Heart valve sclerosis predicts all-cause and cardiovascular mortality.

Authors:  Henry Völzke; Robin Haring; Roberto Lorbeer; Henri Wallaschofski; Thorsten Reffelmann; Klaus Empen; Rainer Rettig; Ulrich John; Stephan B Felix; Marcus Dörr
Journal:  Atherosclerosis       Date:  2009-10-29       Impact factor: 5.162

10.  Transforming growth factor beta 1 promotes the differentiation of endothelial cells into smooth muscle-like cells in vitro.

Authors:  E Arciniegas; A B Sutton; T D Allen; A M Schor
Journal:  J Cell Sci       Date:  1992-10       Impact factor: 5.285

View more
  58 in total

Review 1.  Emerging role of circulating calcifying cells in the bone-vascular axis.

Authors:  Gian Paolo Fadini; Marcello Rattazzi; Tomoyuki Matsumoto; Takayuki Asahara; Sundeep Khosla
Journal:  Circulation       Date:  2012-06-05       Impact factor: 29.690

Review 2.  Plasticity and maintenance of hematopoietic stem cells during development.

Authors:  Suman Kanji; Vincent J Pompili; Hiranmoy Das
Journal:  Recent Pat Biotechnol       Date:  2011-04

3.  Cyclic strain induces dual-mode endothelial-mesenchymal transformation of the cardiac valve.

Authors:  Kartik Balachandran; Patrick W Alford; Jill Wylie-Sears; Josue A Goss; Anna Grosberg; Joyce Bischoff; Elena Aikawa; Robert A Levine; Kevin Kit Parker
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-28       Impact factor: 11.205

Review 4.  Mitral valve disease--morphology and mechanisms.

Authors:  Robert A Levine; Albert A Hagége; Daniel P Judge; Muralidhar Padala; Jacob P Dal-Bianco; Elena Aikawa; Jonathan Beaudoin; Joyce Bischoff; Nabila Bouatia-Naji; Patrick Bruneval; Jonathan T Butcher; Alain Carpentier; Miguel Chaput; Adrian H Chester; Catherine Clusel; Francesca N Delling; Harry C Dietz; Christian Dina; Ronen Durst; Leticia Fernandez-Friera; Mark D Handschumacher; Morten O Jensen; Xavier P Jeunemaitre; Hervé Le Marec; Thierry Le Tourneau; Roger R Markwald; Jean Mérot; Emmanuel Messas; David P Milan; Tui Neri; Russell A Norris; David Peal; Maelle Perrocheau; Vincent Probst; Michael Pucéat; Nadia Rosenthal; Jorge Solis; Jean-Jacques Schott; Ehud Schwammenthal; Susan A Slaugenhaupt; Jae-Kwan Song; Magdi H Yacoub
Journal:  Nat Rev Cardiol       Date:  2015-10-20       Impact factor: 32.419

5.  Non-pathological Chondrogenic Features of Valve Interstitial Cells in Normal Adult Zebrafish.

Authors:  Alina Schulz; Jana Brendler; Orest Blaschuk; Kathrin Landgraf; Martin Krueger; Albert M Ricken
Journal:  J Histochem Cytochem       Date:  2019-01-08       Impact factor: 2.479

Review 6.  Progenitor cells confer plasticity to cardiac valve endothelium.

Authors:  Joyce Bischoff; Elena Aikawa
Journal:  J Cardiovasc Transl Res       Date:  2011-07-26       Impact factor: 4.132

Review 7.  Cellular mechanisms in mitral valve disease.

Authors:  Kareem Salhiyyah; Magdi H Yacoub; Adrian H Chester
Journal:  J Cardiovasc Transl Res       Date:  2011-09-03       Impact factor: 4.132

8.  Tumor Endothelial Cells with Distinct Patterns of TGFβ-Driven Endothelial-to-Mesenchymal Transition.

Authors:  Lin Xiao; Dae Joong Kim; Clayton L Davis; James V McCann; James M Dunleavey; Alissa K Vanderlinden; Nuo Xu; Samantha G Pattenden; Stephen V Frye; Xia Xu; Mark Onaitis; Elizabeth Monaghan-Benson; Keith Burridge; Andrew C Dudley
Journal:  Cancer Res       Date:  2015-01-29       Impact factor: 12.701

9.  CD45 Expression in Mitral Valve Endothelial Cells After Myocardial Infarction.

Authors:  Joyce Bischoff; Guillem Casanovas; Jill Wylie-Sears; Dae-Hee Kim; Philipp E Bartko; J Luis Guerrero; Jacob P Dal-Bianco; Jonathan Beaudoin; Michael L Garcia; Suzanne M Sullivan; Margo M Seybolt; Brittan A Morris; Joshua Keegan; Whitney S Irvin; Elena Aikawa; Robert A Levine
Journal:  Circ Res       Date:  2016-10-06       Impact factor: 17.367

Review 10.  Fibrous scaffolds for building hearts and heart parts.

Authors:  A K Capulli; L A MacQueen; Sean P Sheehy; K K Parker
Journal:  Adv Drug Deliv Rev       Date:  2015-12-04       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.